UroGen Pharma
URGN
#5323
Rank
A$2.33 B
Marketcap
A$47.67
Share price
6.51%
Change (1 day)
22.43%
Change (1 year)

UroGen Pharma (URGN) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : A$0.57 Billion

According to UroGen Pharma's latest financial reports the company's total liabilities are A$0.57 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

UroGen Pharma - Total liabilities on balance sheet (from 2016 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31A$0.45 B-3.54%
2024-12-31A$0.47 B32.47%
2023-12-31A$0.35 B8.12%
2022-12-31A$0.33 B115.29%
2021-12-31A$0.15 B360.36%
2020-12-31A$33.35 M5.75%
2019-12-31A$31.54 M65.04%
2018-12-31A$19.11 M112.11%
2017-12-31A$9.01 M-3.76%
2016-12-31A$9.36 M119.39%
2015-12-31A$4.26 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ORIC Pharmaceuticals
ORIC
A$35.19 M-93.91%๐Ÿ‡บ๐Ÿ‡ธ USA